GPGN Surpass
Trial Completed
-
Adelaide SA | Goolwa SA
Effect of Tirzapetide vs Dulaglutide on CV events in patients with Type 2 Diabetes.
- Self-administered fortnightly injections
Requirements
- Age > 40 years
- BMI > 25 kg/m²
- Type 2 diabetes
- Established CVD
Outpatient Visit
- Clinic visits every 4 months
Payment / Remuneration
- Reimbursed for travel